Evaxion Biotech A/S announces a transformational partnership with MSD on two vaccine candidates for infectious diseases, tracking towards potential option exercise in the second half of 2025. The company also made substantial progress in business development, research and development, and financing in 2024 and the first months of 2025.
Company Information
Company
Evaxion Biotech A/S
Location
Copenhagen, Capital Region Of Denmark, Denmark
About
Evaxion is a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines.
Predictive Intelligence
Strategic
ML-powered predictions for Evaxion Biotech A/S's next move